Patent ID: 9314515
Filing Date: 2016-04-19
CPC Classification: A61K,A61P,C07K,G01N

Claim Text:
1. A method for treating breast cancer, comprising (i) determining the expression of estrogen receptor (ER) and progesterone receptor (PR) in cells of a breast tumor obtained from a subject, and (ii) administering to the subject having the breast tumor that is estrogen receptor and progesterone receptor negative (ER/PR-negative) an amount of one or more of a MAGE antigen protein, a CTAG1b antigen protein, or a CTAG2 antigen protein or one or more immunogenic peptides of a MAGE antigen protein, a CTAG1b antigen protein, or a CTAG2 antigen protein, wherein the breast tumor expresses one or more of the MAGE antigen protein, the CTAG 1b antigen protein, or the CTAG2 antigen protein and the amount is effective to induce or increase an immune response against the one or more proteins and/or peptides.